I have been thinking they might name another eye candidate but they might side swipe us with a cns candidate as well. Now that would turn a few heads. Plenty of revenue in a Parkinson drug i would think, although that would take quite a long time to materialise.
Brain liver and eye... all the hard stuff. A few years and we wont recognise this company.
Ann: Appointment of world-renowned Chief Scientific Officer, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.045(3.46%) |
Mkt cap ! $730.5M | |||
| Open | High | Low | Value | Volume |
| $1.26 | $1.26 | $1.25 | $7.195K | 5.736K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10985 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 4434 | 4 |
View Market Depth
| Last trade - 12.19pm 07/08/2025 (20 minute delay) ? |
| PYC (ASX) Chart |